Pacer Advisors, Inc. Neurocrine Biosciences Inc Transaction History

Pacer Advisors, Inc.

  • $40.5 Billion
  • Q4 2024

A detailed history of Pacer Advisors, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Pacer Advisors, Inc. holds 31,837 shares of NBIX stock, worth $3.79 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
31,837
Previous 28,793 10.57%
Holding current value
$3.79 Million
Previous $3.31 Million 31.11%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 22, 2025
BUY
$111.62 - $139.44 $339,771 - $424,455
3,044 Added 10.57%
31,837 $4.35 Million
Q3 2024

Nov 12, 2024
SELL
$114.58 - $153.15 $354,854 - $474,305
-3,097 Reduced 9.71%
28,793 $3.31 Million
Q2 2024

Aug 13, 2024
BUY
$130.86 - $143.19 $1.8 Million - $1.97 Million
13,782 Added 76.11%
31,890 $4.39 Million
Q1 2024

May 10, 2024
BUY
$130.4 - $143.74 $456,400 - $503,090
3,500 Added 23.96%
18,108 $2.5 Million
Q4 2023

Jan 16, 2024
BUY
$106.07 - $132.76 $684,151 - $856,301
6,450 Added 79.06%
14,608 $1.92 Million
Q3 2023

Nov 13, 2023
SELL
$94.02 - $117.1 $1.16 Million - $1.45 Million
-12,344 Reduced 60.21%
8,158 $917,000
Q2 2023

Jul 12, 2023
BUY
$89.53 - $104.87 $1.84 Million - $2.15 Million
20,502 New
20,502 $1.93 Million
Q4 2022

Feb 06, 2023
BUY
$106.72 - $127.06 $1.52 Million - $1.81 Million
14,218 Added 338.2%
18,422 $2.2 Million
Q3 2022

Oct 18, 2022
BUY
$92.03 - $107.81 $386,894 - $453,233
4,204 New
4,204 $447,000
Q1 2022

Apr 05, 2022
SELL
$72.45 - $94.81 $887,295 - $1.16 Million
-12,247 Closed
0 $0
Q4 2021

Feb 03, 2022
BUY
$79.65 - $106.22 $205,576 - $274,153
2,581 Added 26.7%
12,247 $1.04 Million
Q3 2021

Oct 15, 2021
SELL
$86.18 - $99.03 $20,166 - $23,173
-234 Reduced 2.36%
9,666 $927,000
Q2 2021

Jul 21, 2021
BUY
$89.43 - $102.27 $813,902 - $930,759
9,101 Added 1139.05%
9,900 $963,000
Q1 2021

Apr 05, 2021
SELL
$87.57 - $119.4 $57,445 - $78,326
-656 Reduced 45.09%
799 $78,000
Q4 2020

Jan 20, 2021
BUY
$86.91 - $108.33 $47,105 - $58,714
542 Added 59.36%
1,455 $139,000
Q3 2020

Oct 19, 2020
BUY
$96.16 - $135.15 $87,794 - $123,391
913 New
913 $88,000
Q4 2018

Feb 13, 2019
SELL
$68.32 - $124.36 $181,799 - $330,921
-2,661 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$98.88 - $125.85 $263,119 - $334,886
2,661 New
2,661 $327,000
Q1 2018

May 14, 2018
SELL
$75.88 - $92.43 $146,069 - $177,927
-1,925 Closed
0 $0
Q4 2017

Feb 14, 2018
SELL
$58.53 - $77.59 $509,620 - $675,576
-8,707 Reduced 81.89%
1,925 $149,000
Q3 2017

Nov 08, 2017
BUY
$47.97 - $61.28 $510,017 - $651,528
10,632
10,632 $652,000

Others Institutions Holding NBIX

# of Institutions
654
Shares Held
96.5M
Call Options Held
282K
Put Options Held
281K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.4B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Pacer Advisors, Inc. Portfolio

Follow Pacer Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email